Reitan Colleen F Insider Trading -- Recent SEC Form 4 Transactions

Reitan Colleen F (CIK 1740730) reported 24 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy MYGN (59,701 shares), Buy ALNY (671 shares), Sell ALNY (838 shares), Sell ALNY (1,645 shares), Sell ALNY (1,888 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-06-05MYRIAD GENETICS INC (MYGN)DirectorBuy59,701$0
2026-05-22ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorBuy671$0
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell838$397,396
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,645$752,489
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,888$866,328
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,403$645,001
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell473$217,916
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell2,290$1.1M
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,652$764,876
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell799$371,024
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell222$104,618
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell823$389,131
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorBuy18,000$1.8M
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell951$451,582
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell972$462,973
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,183$564,847
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,450$694,072
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell1,386$664,656
2025-09-11ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell25$12,024
2025-06-06MYRIAD GENETICS INC (MYGN)DirectorBuy49,796$0
2025-05-12ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorBuy32$9,152
2025-05-12ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorBuy4$1,211
2025-05-12ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorSell36$8,383
2025-05-12ALNYLAM PHARMACEUTICALS, INC. (ALNY)DirectorBuy775$0

Source: SEC Form 4 filings · as of 2026-06-05